Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancerReportar como inadecuado

Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Hereditary Cancer in Clinical Practice

, 15:4

First Online: 01 March 2017Received: 11 November 2016Accepted: 11 February 2017DOI: 10.1186-s13053-017-0064-y

Cite this article as: Huzarski, T., Górecka-Szyld, B., Huzarska, J. et al. Hered Cancer Clin Pract 2017 15: 4. doi:10.1186-s13053-017-0064-y


BackgroundThe addition of MRI to mammography and ultrasound for breast cancer screening has been shown to improve screening sensitivity for high risk women, but there is little data to date for women at average or intermediate risk.

MethodsTwo thousand nine hundred and ninety-five women, aged 40 to 65 years with no previous history of breast cancer were enrolled in a screening program, which consisted of two rounds of MRI, ultrasound and mammography, one year apart. Three hundred and fifty-six women had a CHEK2 mutation, 370 women had a first-degree relative with breast cancer and no CHEK2 mutation and 2269 women had neither risk factor. Subjects were followed for breast cancer for three years from the second screening examination.

ResultsTwenty-seven invasive epithelial cancers, one angiosarcoma and six cases of DCIS were identified over the four-year period. Of the 27 invasive cancers, 20 were screen-detected, 2 were interval cancers, and five cancers were identified in the second or third follow-up year i.e., after the end of the screening period. For invasive cancer, the sensitivity of MRI was 86%, the sensitivity of ultrasound was 59% and the sensitivity of mammography was 50%. The number of biopsies incurred by MRI n = 156 was greater than the number incurred by mammography n = 35 or ultrasound n = 57. Of the 19 invasive cancers detected by MRI, 17 89% were also detected by ultrasound or mammography.

ConclusionsIn terms of sensitivity, MRI is slightly better than the combination of mammography and ultrasound for screening of women at average or intermediate risk of breast cancer. However, because of additional costs incurred by MRI screening, and the small gain in sensitivity, MRI screening is probably not warranted outside of high-risk populations.

KeywordsBreast cancer CHEK2 Magnetic resonance imaging Mammography Ultrasound Screening AbbreviationsBI-RADSBreast imaging reporting and data system

DCISDuctal carcinoma in situ

MRIMagnetic resonance imaging

Download fulltext PDF

Autor: Tomasz Huzarski - Barbara Górecka-Szyld - Jowita Huzarska - Grażyna Psut-Muszyńska - Grażyna Wilk - Robert Sibilski - Ce


Documentos relacionados